NOVARTIS VENTURE FUND

The Novartis Venture Fund was created to foster innovation, drive significant patient benefit, and generate superior returns by nurturing and investing in innovative life science companies... We manage over USD 750 million in committed capital and more than 40 portfolio companies across North America and Europe... The Novartis Venture Fund invests in life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.